Michael Hunkapiller joined Alloy in 2004 after 21 years at Applied Biosystems (NYSE: ABI), which he helped grow from startup to almost $2 billion in annual revenues supplying instrument and reagent systems for life science research. At ABI, he held several positions, most recently as President and General Manager. He was also a founder of ABI's sister company Celera Genomics (NYSE: CRA) and Senior Vice President of Applera Corporation (their parent company). Prior to joining ABI, Mike was a senior research fellow in the Division of Biology at the California Institute of Technology. He received a B.S. in Chemistry from Oklahoma Baptist University in 1970 and a Ph.D. in Chemical Biology from the Division of Chemistry and Chemical Engineering at Caltech in 1974. He has authored more than 100 scientific publications, is an inventor on more than two dozen patents, and has served on the editorial boards of several scientific journals. He has received several awards for his contributions to life science research, including the development of the automated DNA sequencing systems used to sequence the human genome. Mike is currently on the board of directors of Codon Devices, Fluidigm, and Pacific Biosciences.